UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000007308
Receipt No. R000008616
Official scientific title of the study RenalGuard System to Prevent Contrast-Induced Acute Kidney Injury in Japan
Date of disclosure of the study information 2012/02/16
Last modified on 2018/09/13 (Ver. 7)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study RenalGuard System to Prevent Contrast-Induced Acute Kidney Injury in Japan
Title of the study (Brief title) RESPECT KIDNEY
Region
Japan

Condition
Condition Chronic kidney disease with coronary aretry disease or peripheral artery disease
Classification by specialty
Medicine in general Cardiology Nephrology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate safety and efficacy of RenalGuard System in the prevention of contrast-induced nephropathy in the setting of a catheterization laboratory
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Combined incidence of contrast-induced nephropathy (CIN) and serious in-hospital therapy-related adverse events
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Prevention
Type of intervention
Device,equipment
Interventions/Control_1 RenalGuard group
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Male or non-pregnant female equal or greater than the age 20 years old and is able to provide informed consent.
Subject is scheduled to undergo an catheterization procedure that is expected to use at least 75 ml of intraarterial contrast.
Subject has moderate to severe kidney impairement-eGFR<45 ml/min/1.73m2 and more than 30 % of ejection fraction of left ventricle.
Key exclusion criteria Class 3 or 4 chronic heart failure.
Subject is anuric or has undergone renal replacement therapy, or has a known inability to have a Foley catheter placed.
Subject has received contrast within 7 days of procedure.
Subject has a known hypersensitivity to furosemide and/or the contrast agent being used.
Target sample size 60

Research contact person
Name of lead principal investigator Ichiro Michishita
Organization Federation of National Public Service Personnel Mutual Aid Associations, Yokohama Sakae Kyosai Hospital
Division name Division of Cardiology, Department of Internal Medicine
Address 132 Katura-cho, Sakae-ku, Yokohama-shi
TEL 045-891-2171
Email i-michishita@yokohamasakae.jp

Public contact
Name of contact person Tsuyoshi Nozue
Organization Yokohama Sakae Kyosai Hospital
Division name Divison of Cardiology, Department of Internal Medicine
Address 132 Katsura-cho, Sakae-ku, Yokohama-shi
TEL 045-891-2171
Homepage URL
Email nozue2493@yahoo.co.jp

Sponsor
Institute Yokohama Sakae Kyosai Hospital
Institute
Department

Funding Source
Organization Yokohama Sakae Kyosai Hospital
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2012 Year 02 Month 16 Day

Progress
Recruitment status Completed
Date of protocol fixation
2013 Year 12 Month 01 Day
Anticipated trial start date
2013 Year 12 Month 01 Day
Last follow-up date
2016 Year 09 Month 30 Day
Date of closure to data entry
2016 Year 09 Month 30 Day
Date trial data considered complete
2016 Year 09 Month 30 Day
Date analysis concluded
2018 Year 12 Month 31 Day

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results
Other related information

Management information
Registered date
2012 Year 02 Month 16 Day
Last modified on
2018 Year 09 Month 13 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000008616